Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nivolumab Treatment for Cancers in the HIV-infected Population.
Chang E, Sabichi AL, Kramer JR, Hartman C, Royse KE, White DL, Patel NR, Richardson P, Yellapragada SV, Garcia JM, Chiao EY. Chang E, et al. Among authors: yellapragada sv. J Immunother. 2018 Oct;41(8):379-383. doi: 10.1097/CJI.0000000000000240. J Immunother. 2018. PMID: 30020193 Free PMC article.
Hypomethylating agents for urologic cancers.
Alva AS, Hahn NM, Aparicio AM, Singal R, Yellapragada S, Sonpavde G. Alva AS, et al. Future Oncol. 2011 Mar;7(3):447-63. doi: 10.2217/fon.11.9. Future Oncol. 2011. PMID: 21417907 Review.
HIV-related Refractory Hodgkin Lymphoma: A Case Report of Complete Response to Nivolumab.
Chang E, Rivero G, Patel NR, Chiao EY, Lai S, Bajaj K, Mbue JE, Yellapragada SV. Chang E, et al. Among authors: yellapragada sv. Clin Lymphoma Myeloma Leuk. 2018 Feb;18(2):e143-e146. doi: 10.1016/j.clml.2017.12.008. Epub 2018 Jan 3. Clin Lymphoma Myeloma Leuk. 2018. PMID: 29342442 Free PMC article. No abstract available.
Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States.
Lurain K, Zarif TE, Ramaswami R, Nassar AH, Adib E, Abdel-Wahab N, Chintapally N, Drolen CE, Feldman T, Haykal T, Nebhan CA, Kambhampati S, Li M, Mittra A, Lorentsen M, Kim C, Drakaki A, Morse M, Johnson DB, Mangla A, Dittus C, Ravi P, Baiocchi RA, Chiao EY, Rubinstein PG, Yellapragada SV, LaCasce AS, Sonpavde GP, Naqash AR, Herrera AF. Lurain K, et al. Among authors: yellapragada sv. Clin Lymphoma Myeloma Leuk. 2024 Apr 5:S2152-2650(24)00134-4. doi: 10.1016/j.clml.2024.03.011. Online ahead of print. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38714474
Using wearables to screen motor performance deterioration because of cancer and chemotherapy-induced peripheral neuropathy (CIPN) in adults - Toward an early diagnosis of CIPN.
Zahiri M, Chen KM, Zhou H, Nguyen H, Workeneh BT, Yellapragada SV, Sada YH, Schwenk M, Najafi B. Zahiri M, et al. Among authors: yellapragada sv. J Geriatr Oncol. 2019 Nov;10(6):960-967. doi: 10.1016/j.jgo.2019.01.010. Epub 2019 Jan 18. J Geriatr Oncol. 2019. PMID: 30665876 Free PMC article.
Contemporary Analysis of Electronic Frailty Measurement in Older Adults with Multiple Myeloma Treated in the National US Veterans Affairs Healthcare System.
DuMontier C, Fillmore NR, Yildirim C, Cheng D, La J, Orkaby AR, Charest B, Cirstea D, Yellapragada S, Gaziano JM, Do N, Brophy MT, Kim DH, Munshi NC, Driver JA. DuMontier C, et al. Cancers (Basel). 2021 Jun 18;13(12):3053. doi: 10.3390/cancers13123053. Cancers (Basel). 2021. PMID: 34207459 Free PMC article.
32 results